PDCD1 and neoplasm: Although SFN injection alone did not induce complete tumor regression, a single meso CAR-T adoptive transfer synergy with SFN showed a stronger ability to delay tumor growth and prolonged survival, which was similar to the effect in conjunction with anti-PD-1 therapy (Fig. 5B–D).